Difference between revisions of "Part:BBa K3506022"

 
(43 intermediate revisions by 7 users not shown)
Line 3: Line 3:
 
<partinfo>BBa_K3506022 short</partinfo>
 
<partinfo>BBa_K3506022 short</partinfo>
  
Inducible double promoter system is composed of <i>GAL7</i>([https://parts.igem.org/Part:BBa_K3506424 BBa_K3506424]) and Cn<i>U6</i>([https://parts.igem.org/Part:BBa_K3506021 BBa_K3506021]).
+
Inducible double promoter system is composed of <i>GAL7</i> promoter([https://parts.igem.org/Part:BBa_K3506424 BBa_K3506424]) and <i>U6</i> promoter([https://parts.igem.org/Part:BBa_K3506021 BBa_K3506021]).
<i>GAL7</i> promoter can be induced by galactose in Cryptococcus neoformans. It is the first inducible promoter characterized in <i>C. neoformans</i>.  
+
<i>GAL7</i> promoter can be induced by galactose in <i>Cryptococcus neoformans</i>. It is the first inducible promoter characterized in <i>Cryptococcus neoformans</i>.  
<i>U6</i> promoter is used to drive the expression of homing guide RNA(hgRNA) in lineage tracing for eukaryotic systems. 
+
<i>U6</i> promoter is used to initiate the expression of guide RNA(gRNA) in lineage tracing for eukaryotic systems. 
  
We put <i>GAL7</i> promoter in the upstream of <i>U6</i> promoter.The system can read the information of snRNAs out of transcriptomic information by polyA tail.  
+
We put <i>GAL7</i> promoter in the upstream of <i>U6</i> promoter. The system can read the information of gRNA together with transcriptomic information by polyA tail.  
  
  
 
<b><font size="3">Biology and Usage</font></b>
 
<b><font size="3">Biology and Usage</font></b>
  
<i>GAL7</i> promoter can be induced by galactose in <i>Cryptococcus neoformans</i> and it is promoted by RNA polymerase II.
+
<i>GAL7</i> promoter can be induced by galactose and it is recognized by RNA polymerase II, which can add the polyA tail to its downstream genes.
RNA polymerase III uniquely transcribes small non-coding RNAs, including 5S rRNA , tRNAs, and other essential RNAs such as the <i>U6</i> snRNA[1]. <i>U6</i> promoter is used to drive the expression of sgRNA in lineage tracing for eukaryotic systems. 
+
  
In our project, we use U6 promoter to transcribe small non-coding RNAs, hgRNA in CRISPR-Cas genome-editing system[2]. We use <i>GAL7</i> promoter to transcribe the hgRNA and add a polyA tail at specific time. So the hgRNA can not only work with CRISPR/Cas system, but also work as barcode. It enable us to read the lineage information out of transcriptomic information.
+
<i>U6</i> promoter is used to initiate the transcription of small non-coding RNAs [1] and it is recognized by RNA polymerase III, which can not add the polyA tail to its downstream genes.  
  
It is known that the RNA polymerase III transcription product does not have polyA, nor can it be captured by Oligo dT for information reading. Therefore, you can use our double promoter system when you need to read the expression levels or information of Pol III transcription product together with transcriptomic information at specific time. This is very significant for knowing the functions and influences of this kind of RNA. Of course, this compound part can be induced, it indicates the possibility to read snRNA information at specific time or tissue.
+
In our project, <i>U6</i> promoter is used to transcribe gRNA constitutively [2], which can be recognized by Cas9. <i>GAL7</i> promoter is used to transcribe the DNA of <i>U6</i> promoter and gRNA at a specific time. So we can add the polyA tail to gRNA when induced, which enables it to be captured by oligo dT in single cell RNA sequencing. Thus, we can obtain the lineage information together with transcriptomic information by single cell RNA sequencing.
  
 +
You can use our double promoter module when you need to read the information of Pol III transcription products together with transcriptomic information at a specific time. This is very significant for knowing the functions and influences of this kind of RNAs.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
Line 30: Line 30:
 
<b><font size="3">Design and Properties</font></b>
 
<b><font size="3">Design and Properties</font></b>
  
[[Image:T--BNU-China--GAL7-U6.png|300px|border|center]]
+
We use <i>U6</i> promoter ([https://parts.igem.org/Part:BBa_K3506021 BBa_K3506021]) to transcribe gRNA, and <i>GAL7</i> promoter ([https://parts.igem.org/Part:BBa_K3506424 BBa_K3506424]) is used to transcribe the DNA of <i>U6</i> promoter and gRNA when induced by galactose.
  
we tested the pU6 and pGAL7 system. The test is divided into two parts.
 
  
First part: to test whether pGAL7 will affect the production and function of hgRNA. We put sgRNA which target <i>ADE2</i> gene downstream of U6 promoter in both experimental group and control group. Put pGAL7 upstream of U6 promoter only in experimental group. Result shows that pGAL7 won’t affect the production and function of gRNA, because both of the two groups turn red.(Figure 1.)
 
  
Second part: to test that whether gRNA can be reverse transcribed by oligo dT. For both experimental group and control group, we extract the total mRNA of these red colonies by TRIzol. Then the mRNA was reverse transcribed by oligo dT. To test whether gRNA can be transcribed, we performed PCR on reverse transcription products by two specfic primers. Agarose gel electrophoresis were performed on the PCR product. There came out a correct band(Figure 2.). Then we sequenced the products to prove the success of our engineer further.
+
We tested the <i>U6</i> promoter and <i>GAL7</i> promoter system. The test is divided into two steps.
[[Image:T--BNU-China--GAL7.jpg|300px|thumb|center|Fig. 1 A. control group(pU6-gDNA); B. experimental group(pGAL7-pU6-gDNA); C. and D. 4500FOA (the recipient strain)]]
+
  
<b><font size="3">Experimental approach</font></b>
+
First step: to test whether <i>GAL7</i> promoter will affect the production and function of gRNA. We put gRNA targeting <i>ADE2</i> gene downstream of <i>U6</i> promoter in both the experimental group and the control group. A loss-of-function mutation in <i>ADE2</i> can result in an adenine auxotroph that forms pink colonies on YNBA plates containing a low level of adenine, thus enabling a visual evaluation of the action of CRISPR/Cas9. Put <i>GAL7</i> promoter upstream of <i>U6</i> promoter only in the experimental group. Results showed that both of the two groups turned red, thus  <i>GAL7</i> promoter won’t affect the production and the function of gRNA(Figure 1.).
  
1.Construct recombinant plasmid. Get pGAL7 from the PYES2 plasmid. Inserted it upstream of pU6 on PRH003 plasmid. Ligate the fragments by in-fusion cloning.  
+
Second step: to test whether gRNA can be reverse transcribed when using oligo dT as the primer. For both the experimental group and the control group, we extracted total mRNA of these pink colonies by TRIzol. Then the mRNA was reverse transcribed using oligo dT as the primer. To test whether gRNA can be transcribed, we performed PCR on reverse transcription products by two specfic primers. Agarose gel electrophoresis was performed on the PCR products. There came out a correct band(Figure 2.). Then we sequenced the products and got the anticipated results.
 +
 
 +
 
 +
[[Image:T--BNU-China--GAL7.jpg|300px|thumb|center|Figure 1. A.The control group(<i>U6</i> promoter-gDNA); B.The experimental group(<i>GAL7</i> promoter-<i>U6</i> promoter-gDNA); C. and D. 4500FOA (the recipient strain)]]
 +
[[Image:T--BNU-China--22.jpg|300px|thumb|center|Figure 2. Gel electrophoresis results of the control group(<i>U6</i> promoter-gDNA) and the experimental group(<i>GAL7</i> promoter-<i>U6</i> promoter-gDNA). Lane 1: Marker; Lane 2 and Lane 3: RT-PCR product of the control group(<i>U6</i> promoter-gDNA); Lane 4 and Lane 5: RT-PCR product of the experimental group(<i>GAL7</i> promoter-<i>U6</i> promoter-gDNA) (208 bp).]]
 +
 
 +
<b><font size="3">Experimental approach</font></b>
  
2.Transform the product (2.5μL) into DH5α competent cells(50μL), coat cells on each agar plate (containing Ampicillin). Incubate plates at 37°C overnight. Monoclones were selected for colony PCR. Expanding culture colonies at 37℃ 200rpm,extract plasmids and sequence.  
+
1. Construct recombinant plasmid. Get <i>GAL7</i> promoter from the genome of <i>Cryptococcus neoformans</i>. Insert it upstream of <i>U6</i> promoter on PRH003 plasmid.  
  
3.Use Kpn1 enzyme to linearise the plasmid and transformed it into <i>Cryptococcus neoformans</i> by electroporation.
+
2. Transform the product (2.5μL) into DH5α competent cells(50μL), grow cells on each agar plate (containing Ampicillin). Incubate plates at 37°C overnight. Monoclones are selected by colony PCR. Expanding culture colonies at 37℃ 200rpm, then extracting plasmids and sequencing.  
  
4.The <i>C. neoformans</i> was spreed on YNBA selection medium, and the transformants grew after being cultured in an 30℃ incubator for days. Then transferred them to a 4℃ refrigerator.  
+
3. Use Kpn1 enzyme to linearise the plasmids and transform them into <i>Cryptococcus neoformans</i> by electroporation.
 +
 
 +
4. The <i>Cryptococcus neoformans</i> is spread on YNBA selection medium, and the transformants grow after being cultured in an incubator at 30℃ for 4 days. Then the culture is transferred to a refrigerator at 4℃.  
  
5.Red colonies were selected and inoculated into YPD medium, then placed it in 30℃ incubator for days, and placed it in 4℃ refrigerator again.  
+
5. Pink colonies are selected and inoculated into YPD medium, then place it in an incubator at 30℃ for 4 days.  Finally it is kept at 4℃ refrigerator.
 +
 +
6. For both the experimental group and the control group, we select pink colonies. They are induced by galactose for 30mins. Then we extract the total mRNA by TRIzol. The mRNA is reverse transcribed using oligodT as the primer.
  
6.For both experimental group and control group, we selected red colonies, induced by galactose for 30mins, extract the total mRNA by TRIzol. Then the mRNA was reverse transcribed by oligo dT.
+
7. To test whether gRNA can be transcribed, we perform PCR on reverse transcription products by two specfic primers. Then sequencing the PCR product to further prove the success of our design .
  
7.To test whether gRNA can be transcribed, we performed PCR on reverse transcription products by two specfic primers. Then sequence the PCR product to proved the success of our design further.
 
  
 
<b><font size="3">References</font></b>
 
<b><font size="3">References</font></b>
  
[1]Duttke, S. H C . RNA polymerase III accurately initiates transcription from RNA polymerase II promoters in vitro.[J]. Journal of Biological Chemistry, 2014, 289(29):20396.
+
[1]Duttke S. H. (2014). RNA polymerase III accurately initiates transcription from RNA polymerase II promoters in vitro. The Journal of biological chemistry, 289(29), 20396–20404.
  
  

Latest revision as of 04:00, 28 October 2020


Inducible double promoter system

Inducible double promoter system is composed of GAL7 promoter(BBa_K3506424) and U6 promoter(BBa_K3506021). GAL7 promoter can be induced by galactose in Cryptococcus neoformans. It is the first inducible promoter characterized in Cryptococcus neoformans. U6 promoter is used to initiate the expression of guide RNA(gRNA) in lineage tracing for eukaryotic systems. 

We put GAL7 promoter in the upstream of U6 promoter. The system can read the information of gRNA together with transcriptomic information by polyA tail.


Biology and Usage

GAL7 promoter can be induced by galactose and it is recognized by RNA polymerase II, which can add the polyA tail to its downstream genes.

U6 promoter is used to initiate the transcription of small non-coding RNAs [1] and it is recognized by RNA polymerase III, which can not add the polyA tail to its downstream genes.

In our project, U6 promoter is used to transcribe gRNA constitutively [2], which can be recognized by Cas9. GAL7 promoter is used to transcribe the DNA of U6 promoter and gRNA at a specific time. So we can add the polyA tail to gRNA when induced, which enables it to be captured by oligo dT in single cell RNA sequencing. Thus, we can obtain the lineage information together with transcriptomic information by single cell RNA sequencing.

You can use our double promoter module when you need to read the information of Pol III transcription products together with transcriptomic information at a specific time. This is very significant for knowing the functions and influences of this kind of RNAs.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 402
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 742


Design and Properties

We use U6 promoter (BBa_K3506021) to transcribe gRNA, and GAL7 promoter (BBa_K3506424) is used to transcribe the DNA of U6 promoter and gRNA when induced by galactose.


We tested the U6 promoter and GAL7 promoter system. The test is divided into two steps.

First step: to test whether GAL7 promoter will affect the production and function of gRNA. We put gRNA targeting ADE2 gene downstream of U6 promoter in both the experimental group and the control group. A loss-of-function mutation in ADE2 can result in an adenine auxotroph that forms pink colonies on YNBA plates containing a low level of adenine, thus enabling a visual evaluation of the action of CRISPR/Cas9. Put GAL7 promoter upstream of U6 promoter only in the experimental group. Results showed that both of the two groups turned red, thus GAL7 promoter won’t affect the production and the function of gRNA(Figure 1.).

Second step: to test whether gRNA can be reverse transcribed when using oligo dT as the primer. For both the experimental group and the control group, we extracted total mRNA of these pink colonies by TRIzol. Then the mRNA was reverse transcribed using oligo dT as the primer. To test whether gRNA can be transcribed, we performed PCR on reverse transcription products by two specfic primers. Agarose gel electrophoresis was performed on the PCR products. There came out a correct band(Figure 2.). Then we sequenced the products and got the anticipated results.


Figure 1. A.The control group(U6 promoter-gDNA); B.The experimental group(GAL7 promoter-U6 promoter-gDNA); C. and D. 4500FOA (the recipient strain)
Figure 2. Gel electrophoresis results of the control group(U6 promoter-gDNA) and the experimental group(GAL7 promoter-U6 promoter-gDNA). Lane 1: Marker; Lane 2 and Lane 3: RT-PCR product of the control group(U6 promoter-gDNA); Lane 4 and Lane 5: RT-PCR product of the experimental group(GAL7 promoter-U6 promoter-gDNA) (208 bp).

Experimental approach

1. Construct recombinant plasmid. Get GAL7 promoter from the genome of Cryptococcus neoformans. Insert it upstream of U6 promoter on PRH003 plasmid.

2. Transform the product (2.5μL) into DH5α competent cells(50μL), grow cells on each agar plate (containing Ampicillin). Incubate plates at 37°C overnight. Monoclones are selected by colony PCR. Expanding culture colonies at 37℃ 200rpm, then extracting plasmids and sequencing.

3. Use Kpn1 enzyme to linearise the plasmids and transform them into Cryptococcus neoformans by electroporation.

4. The Cryptococcus neoformans is spread on YNBA selection medium, and the transformants grow after being cultured in an incubator at 30℃ for 4 days. Then the culture is transferred to a refrigerator at 4℃.

5. Pink colonies are selected and inoculated into YPD medium, then place it in an incubator at 30℃ for 4 days. Finally it is kept at 4℃ refrigerator.

6. For both the experimental group and the control group, we select pink colonies. They are induced by galactose for 30mins. Then we extract the total mRNA by TRIzol. The mRNA is reverse transcribed using oligodT as the primer.

7. To test whether gRNA can be transcribed, we perform PCR on reverse transcription products by two specfic primers. Then sequencing the PCR product to further prove the success of our design .


References

[1]Duttke S. H. (2014). RNA polymerase III accurately initiates transcription from RNA polymerase II promoters in vitro. The Journal of biological chemistry, 289(29), 20396–20404.